Loading...
Market
What regulatory changes will occur in pharmaceutical practices by the end of 2025?
5
Resolution / Starting Odds
Stricter warning label requirements • 25%
Increased penalties for non-compliance • 25%
Mandatory ethnic-specific testing • 25%
No significant changes • 25%
Government health agency announcements and policy updates
Story
Bristol-Myers and Sanofi Ordered to Pay $916 Million in Hawaii Plavix Case on May 21, 2024
May 22, 2024, 04:12 PM
A judge in Hawaii has ordered Bristol-Myers Squibb Co. and Sanofi to pay more than $916 million to the state for failing to warn non-white patients, particularly those of East Asian or Pacific Island ancestry, about potential health risks associated with their blood thinner Plavix. The ruling, issued on Tuesday, May 21, 2024, increases the companies' liability from an earlier judgment of $834 million.
View original story
Similar markets
New federal regulations adopted • 25%
Industry-wide standards revised • 25%
No significant changes • 25%
Only minor adjustments made • 25%
Increase in oversight or auditing • 33%
Reduction in funding • 33%
No significant changes • 34%
Further research commissioned • 25%
Public awareness campaign launched • 25%
No significant action taken • 25%
Immediate regulation or restrictions imposed • 25%
Increased enforcement • 33%
Reduced enforcement • 33%
No significant change • 33%
Major overhaul • 33%
Minor adjustments • 33%
No significant changes • 33%
More firms investigated • 25%
Sanctions imposed • 25%
No significant actions • 25%
Other actions • 25%
Policy becomes more restrictive • 33%
No change in policy • 33%
Policy becomes less restrictive • 34%
New restrictions on menthol cigarettes • 25%
Regulations on flavored e-cigarettes • 25%
Increased age limits for tobacco purchase • 25%
No major new regulations • 25%
Increase in states legalizing recreational use • 25%
Increase in states legalizing medical use • 25%
No significant change • 25%
States tightening restrictions • 25%